ストックスクリーナーアプリを入手
0.3677
0.99%
0.0036
前日終値:
$0.3641
開ける：
$0.37
24時間の取引高:
346.62K
Relative Volume:
0.60
時価総額：
$21.59M
収益：
-
当期純損益:
$-123.46M
株価収益率:
-0.142
EPS:
-2.59
ネットキャッシュフロー:
$-104.11M
1週間 パフォーマンス:
+4.25%
1か月 パフォーマンス:
-6.65%
6か月 パフォーマンス:
-20.86%
1年 パフォーマンス:
-80.44%
1日の値動き範囲:
$0.3566
$0.3781
1週間の範囲:
$0.34
$0.397
52週間の値動き範囲:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
BCAB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.3677 | 21.38M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-13 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-05-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-06-28 | 開始されました | ROTH Capital | Buy |
| 2021-05-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-01-11 | 開始されました | BTIG Research | Buy |
| 2021-01-11 | 開始されました | Credit Suisse | Outperform |
| 2021-01-11 | 開始されました | JP Morgan | Overweight |
| 2021-01-11 | 開始されました | Jefferies | Buy |
すべてを表示
Bioatla Inc (BCAB) 最新ニュース
Has BioAtla Inc. formed a bullish divergenceTrade Entry Summary & Free Daily Entry Point Trade Alerts - Newser
How to forecast BioAtla Inc. trends using time seriesWeekly Loss Report & Weekly Hot Stock Watchlists - Newser
Combining price and volume data for BioAtla Inc.Market Movers & Fast Entry Momentum Trade Alerts - Newser
What technical models suggest about BioAtla Inc.’s comebackJuly 2025 Rallies & Verified Entry Point Detection - Newser
Will BioAtla Inc. see short term momentum2025 EndofYear Setup & Trade Opportunity Analysis - Newser
Exit strategy if you’re trapped in BioAtla Inc.Quarterly Trade Summary & Risk Managed Investment Signals - Newser
Can BioAtla Inc. rally from current levels2025 Support & Resistance & Capital Protection Trading Alerts - Newser
BioAtla downgraded to Market Perform from Outperform at Citizens JMP - MSN
Using data filters to optimize entry into BioAtla Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
BioAtla’s Earnings Call: Positive Clinical Progress Amid Financial Challenges - MSN
JMP Securities Reiterates “Market Perform” Rating for BioAtla (NASDAQ:BCAB) - Defense World
BioAtla (NASDAQ:BCAB) Rating Lowered to Market Perform at Citizens Jmp - Defense World
How sentiment analysis helps forecast BioAtla Inc.Weekly Trend Summary & AI Powered Market Trend Analysis - Newser
BioAtla's BCAB Downgraded to Market Perform by JMP Securities - AInvest
HC Wainwright Predicts BioAtla’s Q3 Earnings (NASDAQ:BCAB) - Defense World
BioAtla’s SWOT analysis: oncology biotech’s stock faces cash crunch - Investing.com
BioAtla stock downgraded by Citizens JMP on cash concerns - Investing.com Australia
Will BioAtla Inc. see short term momentum [2025 Market Trends]Accurate Intraday Trading Signals - Newser
Why BioAtla Inc. stock attracts strong analyst attentionDay Trading Plan with Entry Risk Management - Newser
Analysts Apply Wyckoff Model to BioAtla Inc. StockBuy Low Sell High Stock Watch Strategy in Focus - 선데이타임즈
BioAtla, Inc. (NASDAQ:BCAB) Q2 2025 Earnings Call Transcript - Insider Monkey
What makes BioAtla Inc. stock price move sharplyWatchlist Generator for Smart Money Signals - Newser
BioAtla Inc. stock trend outlook and recovery pathFree Stable Entry High Return Opportunities - Newser
Buy Signal for BioAtla Inc. Stock Key Technical Indicators to WatchFree Conservative Entry for High Return Setup - Newser
What institutional flow reveals about BioAtla Inc.Automated AI Forecast with Trading Alerts - Newser
BioAtla Inc. Testing Reversal Zone on Weekly ChartAI Trading Suggestions With Accuracy Focus Released - beatles.ru
Can BioAtla Inc. Outperform Peers After Recent PullbackFundamental + Technical Hybrid Stock Tips Shared - beatles.ru
Does BioAtla Inc. stock have upside surprise potentialDaily Breakout Recap Watch - sisaissue.com
BioAtla, Inc. Reports Q2 2025 Financial Results and Clinical Progress - TipRanks
Head-To-Head Review: Alzamend Neuro (NASDAQ:ALZN) & BioAtla (NASDAQ:BCAB) - Defense World
Sector ETF performance correlation with BioAtla Inc.Free Alpha Driven Watchlist With Alerts - Newser
Comparing BioAtla Inc. in custom built stock radarsFree Swing Setup With Technical Confirmation - Newser
BioAtla's Strategic Position in Immuno-Oncology and Partnership-Driven Growth - AInvest
BioAtla August 2025 slides: promising clinical data amid financial headwinds By Investing.com - Investing.com Nigeria
Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts - Investing.com India
BioAtla August 2025 slides: promising clinical data amid financial headwinds - Investing.com
BioAtla Inc Reports Q2 2025 EPS of -$0.32, Missing Estimates; Net Loss at $18.7 Million - AInvest
Bioatla Inc (BCAB) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):